Hepatocellular carcinoma in Latin America

Hepatocellular Carcinoma: A Global Challenge

Volumn , Issue , 2012, Pages 55-68

  Pujol, Flor Helene ^a   Roman, Sonia ^b   Panduro, Arturo ^b   Navas, Maria Cristina ^c   Lampe, Elizabeth ^d  

^a Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888587654     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide:IARC CancerBase No. 10 [Internet]. Lyon, France:International Agency for Research on Cancer; 2010. Available from:http://globocan.iarc.fr.
2. Yang JD, Roberts LR 2010, Hepatocellular carcinoma:a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448-458.
3. Vivas Arceo C, Bastidas Ramirez BE, Panduro A. Hepatocellular carcinoma is rarely present in Western Mexico. Hepatology Research 1999; 44:1401-1403.
4. Roman S, Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez-VanDyck, Martinez-Lopez E, Ruiz-Madrigal B, Hernandez-Nazara Z. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico:a systemic review. Hepatology International 2009;3:343-335.
5. Goncalves CS, Pereira FE, Gayotto LCC. Hepatocellular carcinoma in Brazil:report of a national survey (Florianopolis, SC, 1995). Rev Inst. Med Trop S. Paulo, 1997; 39:165-170.
6. Pimenta JR, Massabki PS. Hepatocellular carcinoma:a clinical outlook. Rev Bras Clin Med, 2010; 8:59-67.
7. Ochoa LF, Montoya LP. Mortalidad por cáncer en Colombia en el año 2000:cuando aumentar no es mejorar. CES Medicina. 2003; 17:7-22.
8. Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol. 2010; 16:3603-3615.
9. Wang LY, You SL, Lu SN, Ho HC, Wu MH, Sun CA, Yang HI, Chien-Jen C. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking:a cohort of 2416 HBsAg-seropositive and 9421 HBsAgseronegative male residents in Taiwan. Cancer Causes Control. 2003; 14:241-250.
10. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5:558-567.
11. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol 2001; 82:693-712.
12. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000; 13:223-235.
13. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development:a meta-analysis. J Hepatol. 2009; 50:1142-1154.
14. Monto A. Hepatitis C and steatosis. Semin Gastrointest Dis. 2002; 13:40-46.
15. Zhu AX, Chung RT. Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma? Cancer. 2003; 97:2948-2950.
16. Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA. Epidemiology of HCV infection in Latin America. Ann Hepatol. 2010;9:S2-S27.
17. Pujol FH. Molecular epidemiology of hepatitis viruses in Latin America and Amerindians. Virus Rev Res. 2009; 14:7-15.
18. Cristina J. Genetic diversity and evolution of hepatitis C virus in the Latin American region. J Clin Virol. 2005; 34(Suppl 2):S1-S7.
19. Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, Spinelli V, Pereira LM, Coelho HS, Silva AO, Fonseca JC, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005; 38:41-49.
20. Panduro A, Roman S, Khan S, Tanaka Y, Kurbanov F, Martinez-Lopez E, Campollo O, Hernandez-Nazara Z, Mizokami M. Molecular epidemiology of hepatitis C virus genotypes in West Mexico. Virus Research 2010; 151:19-25.
21. Fassio E, Díaz S, Santa C, Reig ME, Martínez Artola Y, Alves de Mattos A, Míguez C, Galizzi J, Zapata R, Ridruejo E, de Souza FC, Hernández N, Pinchuk L; Multicenter Group for Study of Hepatocarcinoma in Latin America; Asociación Latinoamericana para el Estudio del Hígado (ALEH). Etiology of hepatocellular carcinoma in Latin America:a prospective, multicenter, international study. Ann Hepatol. 2010; 9:63-69.
22. Leão-Filho GC, Lopes EPA, Ferraz AAB, Moura I, Pernambuco JR, Reis C, Silva AEB, Ferraz MCG. Hepatitis G Virus Infection in Patients with Hepatocellular Carcinoma in Recife, Brazil. Jpn J Clin Oncol 2007; 37:632-636.
23. Narciso GR, Nader LA, Maggione LS, Kupsi C. Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis. Sciencia Medica, Porto Alegre:PUCRS, 2006; 9:157-161.
24. Pannain VLN; Bottino AC; Santos RTM; Coelho HSM; Ribeiro-Filho J; Alves VAF. Detecção imunoistoquímica das oncoproteínas p21ras, c-myc e p53 no carcinoma hepatocelular e no tecido hepático não-neoplásico. Arq Gastroenterol. 2004; 41:225-228.
25. Alencar RS, Gomes MM, Sitnik R, Pinho JR, Malta FM, Mello IM, Mello ES, Bacchella T, Machado MC, Alves VA, Carrilho FJ. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res. 2008; 41:235-240.
26. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25:S3-S8.
27. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158-S168.
28. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine. 2000;18:S17-S9.
29. Devesa M, Pujol FH. Hepatitis B virus genetic diversity in Latin America. Virus Res. 2007;127:177-184.
30. Duarte MC, Cardona N, Poblete F, González K, García M, Pacheco M, Botto C, Pujol FH, Williams JR. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela. Trop Med Int Health. 2010;15:924-933.
31. Parana R, Almeida D. HBV epidemiology in Latin America. J Clin Virol. 2005;34:S130-S133.
32. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3:334-342.
33. Pujol FH, Navas MC, Hainaut P, Chemin I. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett. 2009;286:80-88.
34. Livingston SE, Simonetti J, McMahon B, Bulkow L, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP. Hepatitis B virus genotypes in Alaska Native People with hepatocellular carcinoma:preponderance of genotype F. J Infect Dis 2007;195:5-11.
35. Bustíos Sánchez C, Díaz Ferrer J, Román Vargas R, Dávalos Moscol M, Zumaeta Villena E. Clinical-Epidemiological characteristics of the Hepatocellular Carcinoma and treatment in the department of digestive system diseases of the National Hospital "Eduardo Rebagliatti Martins" (HNERM)-ESSALUD Rev Gastroenterol Peru. 2009;29:17-23.
36. Roman S, Tanaka Y, Khan A, Kurbanov, Hideaki K, Mizokami M, Panduro A. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol. 2010;82:1527-1536.
37. Sanchez LV, Tanaka Y, Maldonado M, Mizokami M, Panduro A. Difference of hepatitis B virus genotype distribution in two groups of Mexican patients with different risk factors. High prevalence of genotype H and G. Intervirology. 2007;50:9-15.
38. Pereira LM, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, Moreira RC, Figueiredo GM, Ximenes RA; Hepatitis Study Group. Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg. 2009;81:240-247.
39. Mello FC, Souto FJ, Nabuco LC, Villela-Nogueira CA, Coelho HS, Franz HC, Saraiva JC, Virgolino HA, Motta-Castro AR, Melo MM, Martins RM, Gomes SA. Hepatitis B virus genotypes circulating in Brazil:molecular characterization of genotype F isolates. BMC Microbiol. 2007;7:103.
40. Cotrim H, Mota E, Leite L, Silva L, Lyra L. A case-control study on the association of hepatitis B virus infection and hepatocellular carcinoma in northeast Brazil. Rev Saude Publica. 1992;26:301-305.
41. Miranda EC, Moia LJ, Amaral IS, Barbosa MS, Conde SR, Araújo MT, Cruz ER, Demachki S, Bensabath G, Soares MC. Hepatitis B and C virus infection and the hepatocellular carcinoma in the East Amazon, Brazil. Rev Soc Bras Med Trop. 2004;37:S47-S51.
42. Pezzano SC, Torres C, Fainboim HA, Bouzas MB, Schroder T, Giuliano SF, Paz S, Alvarez E, Campos RH, Mbayed VA. Hepatitis B virus in Buenos Aires, Argentina:genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect. 2010:in presss.
43. Hollinger FB, Sood G. Occult hepatitis B virus infection:a covert operation. J Viral Hepat. 2010; 17:1-15.
44. Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett. 2009;286:52-59.
45. De Mitri MS, Cassini R, Bernardi M. Hepatitis B virus-related hepatocarcinogenesis:molecular oncogenic potential of clear or occult infections. Eur J Cancer. 2010;46:2178-2186.
46. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol. 2004;73:200-207.
47. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. A 28-year study of the course of hepatitis Delta infection:a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136:1629-1638.
48. Kiesslich D, Crispim MA, Santos C, Ferreira Fde L, Fraiji NA, Komninakis SV, Diaz RS. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. J Infect Dis. 2009;199:1608-1611.
49. Anuario Estadístico de Mortalidad, series 2001-2008. Secretaria de Salud de Mexico. Cited July 2010. http://www.sinais.salud.gob.mx/mortalidad/index.html.
50. Wild CP, Montesano R. A model of interaction:aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett. 2009;286:22-28.
51. Wild CP, Gong YY. Mycotoxins and human disease:a largely ignored global health issue. Carcinogenesis. 2010;31:71-82.
52. Gouas D, Shi H, Hainaut P. The aflatoxin-induced TP53 mutation at codon 249 (R249S):biomarker of exposure, early detection and target for therapy. Cancer Lett. 2009;286:29-37.
53. Liu Y & Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma:A risk assessment. Environmental Health Perspectives 2010;118:818-824.
54. Guzman-de-Peňa D & Peňa-Cabriales JJ. Regulatory considerations of aflatoxin contamination of food in Mexico. Rev Latinoamer Microbiol. 2005;47:160-164.
55. Anguiano-Ruvalcaba GL, Verver & Vargas-Cortina A, Guzman-de-Peňa D. Inactivation of aflatoxin B1 and aflatoxicol through "nixtamalizacion" of corn and their regeneration by acidication of corn dough. Salud Publica Mex 2005;47:369-375.
56. Alvarez MT, Castañeda C, Escobar A, Fragoso T. Aflatoxin detection in urine in liver diseases in childhood. G E N. 1991;45:205-219.
57. Nogueira JA, Ono-Nita SK, Nita ME, de Souza MM, do Carmo EP, Mello ES, Scapulatempo C, Paranaguá-Vezozzo DC, Carrilho FJ, Alves VA. TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer. 2009;9:204-249.
58. Diaz GJ, Espitia E. Occurrence of aflatoxin M1 in retail milk samples from Bogotá, Colombia. Food Addit Contam. 2006;23:811-815.
59. Williams R 2006, Global challenges in liver disease. Hepatology. 2006 Sep;44:521-526.
60. WHO. Immunization surveillance, assessment and monitoring. 2010.
61. De la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine:factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12:183-189.
62. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev. 2005;18:12-29.
63. Chiquete E and Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico:A systematic review. Intervirology. 2007;50:1-8.
64. Chiquete E, Sanchez LV, Panduro A. Routes of infection and clinical outcome of Mexican women reactive to anti-hepatitis C virus antibodies. Hepatol Res. 2006;36:1001-106.
65. Vazquez-Vandyck, Roman S, Vazquez JL, Huacuja L, Khalsa G, Troyo-SanRoman R, Panduro A. Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance sydrome. World J Gastroenterol. 2007;13:6213-6218.
66. Mondragon-Sanchez R, Gurduňo-Lopez AL, Hernandez-Castillo E, Gomez-Gomez E, Ruiz-Molina JM. Hepatocellular carcinoma and hepatitis C in Mexico. Hepatogastroenterology. 2005;52:1159-1162.
67. Daruich J, Gadano A, Fainboim H, Pessoa M, Cheinquer H. Latin American guideline for the treatment of chronic hepatitis B. Acta Gastroenterol Latinoam. 2007;37:168-177.
68. Latin American Association for the Study of the Liver. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C. Ann Hepatol. 2010;9:S8-S26.
69. Alsina AE. Liver transplantation for hepatocellular carcinoma. Cancer Control. 2010 17:83-86.
70. Coelho GR, Vasconcelos KF, Vasconcelos JB, Barros MA, Costa PE, Borges GC, Júnior JT, Brasil IR, Filho DH, Viana CF, Rocha TD, Mesquita DF, Garcia JH. Orthotopic liver transplantation for hepatocellular carcinoma:one center's experience in the Northeast of Brazil. Transplant Proc. 2009;41:1740-1742.
71. Gabrielli M, Vivanco M, Hepp J, Martínez J, Pérez R, Guerra J, Arrese M, Figueroa E, Soza A, Yáñes R, Humeres R, Rios H, Palacios JM, Zapata R, Sanhueza E, Contreras J, Rencoret G, Rossi R, Jarufe N. Liver transplantation results for hepatocellular carcinoma in Chile. Transplant Proc. 2010;42:299-301.
72. Hepp J, Innocenti FA. Liver transplantation in Latin America:current status. Transplant Proc. 2004;36:1667-1668.
73. Tanwar S, Khan SA, Grover VP, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol. 2009;15:5511-5516.
74. González I, Abdo AA, López O, Hernández JC, Samada M, Cepero M, Ramos L, Ysla R, Madrigal G, Collera SA, Dominguez J, Diaz J, Benitez PP, Castellanos R. First 100 liver transplants at the medico-surgical research center (CIMEQ). Transplant Proc. 2006;38:2473-2474.
75. González-Rapado L, Abdo A, Hernández H, Cepero M, Samada M, Ramos L, Ysla R, Gómez F, Delgado D, Melián K, González C, Pérez J, Bernardos A. Results of liver transplantation at the Cuban Center for Medical and Surgical Research. Transplant Proc. 2008;40:2983-2984.
76. Meza-Junco J, Montaňo-Lopez A, Candelaria M. Modalidades de tratamiento para pacientes con carcinoma hepatocelular:una serie retrospectiva de una sola institución en Mexico. Gastroenterologia y Hepatologia 2004;27:11-17.